The presence of TDP-43 neuropathology in ~97% of ALS and ~50% of FTLD cases [4] provides a molecular link, connecting both diseases as a clinicopathological spectrum of the TDP-43 proteinopathies [1,5,6]. Here, TARDBP is linked to proteostasis deficiencies.